HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles R Harrington Selected Research

Prion Diseases (Transmissible Spongiform Encephalopathies)

1/2021Tau Protein Phosphorylated at Threonine-231 is Expressed Abundantly in the Cerebellum in Prion Encephalopathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles R Harrington Research Topics

Disease

39Alzheimer Disease (Alzheimer's Disease)
04/2024 - 11/2008
10Tauopathies
04/2024 - 02/2012
7Dementia (Dementias)
04/2024 - 12/2009
7Parkinson Disease (Parkinson's Disease)
03/2024 - 01/2017
5Synucleinopathies
03/2024 - 01/2017
5Neurodegenerative Diseases (Neurodegenerative Disease)
03/2024 - 01/2017
5Cognitive Dysfunction
01/2023 - 01/2009
5Atrophy
04/2022 - 01/2018
4Frontotemporal Dementia (Semantic Dementia)
01/2021 - 01/2020
1Nervous System Diseases (Neurological Disorders)
01/2024
1Amyloid Plaque
02/2021
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
02/2021
1Memory Disorders (Memory Loss)
01/2021
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2021
1Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2021
1Brain Diseases (Brain Disorder)
01/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1COVID-19
01/2021
1Disease Progression
11/2020
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2020
1Neuroblastoma
01/2019
1Motor Disorders
01/2019
1Neurobehavioral Manifestations
01/2017

Drug/Important Bio-Agent (IBA)

22tau Proteins (tau Protein)IBA
04/2024 - 02/2012
14hydromethylthionineIBA
04/2024 - 01/2017
9Proteins (Proteins, Gene)FDA Link
12/2023 - 12/2009
7Amyloid (Amyloid Fibrils)IBA
04/2021 - 02/2012
4alpha-SynucleinIBA
03/2024 - 12/2009
4SynucleinsIBA
01/2024 - 01/2017
3Cholinergic Agents (Cholinergics)IBA
04/2024 - 01/2009
3Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2020
2SNARE Proteins (SNAREs)IBA
04/2024 - 12/2009
2Cholinesterase Inhibitors (Anticholinesterases)IBA
04/2024 - 01/2020
2Rivastigmine (Exelon)FDA LinkGeneric
04/2024 - 04/2022
2Peptides (Polypeptides)IBA
04/2021 - 02/2021
2PrionsIBA
01/2021 - 01/2018
1dityrosineIBA
10/2022
1Mesylates (Mesylate)IBA
01/2022
1MCOIBA
01/2021
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2021
1MetalsIBA
01/2021
1Glial Fibrillary Acidic ProteinIBA
01/2021
1Matrix Metalloproteinases (MMPs)IBA
01/2021
1AngiotensinsIBA
01/2021
1Memantine (Namenda)FDA Link
01/2020
1Cysteine (L-Cysteine)FDA Link
10/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1DisulfidesIBA
11/2017
1Methylene Blue (Methylthioninium Chloride)FDA Link
12/2016
1Carrier Proteins (Binding Protein)IBA
05/2013
1S100 Calcium Binding Protein A6IBA
05/2013
1Qa-SNARE Proteins (Syntaxin)IBA
12/2009
1Coloring Agents (Dyes)IBA
11/2008
1thiazin redIBA
11/2008
1Amyloid beta-PeptidesIBA
11/2008

Therapy/Procedure

10Therapeutics
03/2024 - 04/2014
2Activities of Daily Living (ADL)
01/2018 - 12/2016